Dimensional Fund Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.76M | Sell |
731,586
-278,795
| -28% | -$2.31M | ﹤0.01% | 2363 |
|
|
2026
Q1 | $8.46M | Buy |
1,010,381
+106,530
| +12% | +$1.12M | ﹤0.01% | 2309 |
|
|
2025
Q4 | $13M | Sell |
903,851
-201,176
| -18% | -$2.51M | ﹤0.01% | 2192 |
|
|
2025
Q3 | $10.7M | Sell |
1,105,027
-17,736
| -2% | -$157K | ﹤0.01% | 2279 |
|
|
2025
Q2 | $9.22M | Sell |
1,122,763
-24,963
| -2% | -$209K | ﹤0.01% | 2307 |
|
|
2025
Q1 | $8.21M | Sell |
1,147,726
-23,696
| -2% | -$176K | ﹤0.01% | 2327 |
|
|
2024
Q4 | $9.05M | Buy |
1,171,422
+21,234
| +2% | +$199K | ﹤0.01% | 2348 |
|
|
2024
Q3 | $12.1M | Buy |
1,150,188
+42,735
| +4% | +$521K | ﹤0.01% | 2223 |
|
|
2024
Q2 | $13M | Sell |
1,107,453
-89,620
| -7% | -$1.39M | ﹤0.01% | 2146 |
|
|
2024
Q1 | $25.2M | Sell |
1,197,073
-29,884
| -2% | -$532K | 0.01% | 1870 |
|
|
2023
Q4 | $22M | Buy |
1,226,957
+34,385
| +3% | +$606K | 0.01% | 1940 |
|
|
2023
Q3 | $19.6M | Sell |
1,192,572
-195,442
| -14% | -$3.54M | 0.01% | 1934 |
|
|
2023
Q2 | $27.7M | Sell |
1,388,014
-148,117
| -10% | -$2.85M | 0.01% | 1744 |
|
|
2023
Q1 | $29M | Buy |
+1,536,131
| New | +$34M | 0.01% | 1705 |
|
|
2022
Q3 | $33.1M | Buy |
1,254,101
+176,607
| +16% | +$5.24M | 0.01% | 1517 |
|
|
2022
Q2 | $26.6M | Buy |
1,077,494
+298,352
| +38% | +$7.45M | 0.01% | 1701 |
|
|
2022
Q1 | $25.9M | Buy |
779,142
+29,670
| +4% | +$824K | 0.01% | 1834 |
|
|
2021
Q4 | $24.5M | Buy |
749,472
+82,730
| +12% | +$2.82M | 0.01% | 1878 |
|
|
2021
Q3 | $27.9M | Sell |
666,742
-285,141
| -30% | -$10.3M | 0.01% | 1824 |
|
|
2021
Q2 | $37M | Buy |
951,883
+124,616
| +15% | +$4.46M | 0.01% | 1679 |
|
|
2021
Q1 | $28.2M | Buy |
827,267
+135,823
| +20% | +$5.79M | 0.01% | 1847 |
|
|
2020
Q4 | $31.4M | Buy |
691,444
+6,198
| +0.9% | +$217K | 0.01% | 1725 |
|
|
2020
Q3 | $18.9M | Sell |
685,246
-16,631
| -2% | -$542K | 0.01% | 1888 |
|
|
2020
Q2 | $25.9M | Buy |
701,877
+15,078
| +2% | +$562K | 0.01% | 1716 |
|
|
2020
Q1 | $22.2M | Sell |
686,799
-3,317
| -0.5% | -$138K | 0.01% | 1669 |
|
|
2019
Q4 | $28.3M | Buy |
690,116
+47,911
| +7% | +$1.89M | 0.01% | 1855 |
|
|
2019
Q3 | $22.9M | Buy |
642,205
+83,390
| +15% | +$3.38M | 0.01% | 1924 |
|
|
2019
Q2 | $28.7M | Buy |
558,815
+108,836
| +24% | +$5.43M | 0.01% | 1848 |
|
|
2019
Q1 | $25.8M | Buy |
449,979
+128,266
| +40% | +$6.35M | 0.01% | 1913 |
|
|
2018
Q4 | $13.5M | Buy |
321,713
+196,944
| +158% | +$11.6M | 0.01% | 2197 |
|
|
2018
Q3 | $9.42M | Buy |
124,769
+106,198
| +572% | +$7.65M | ﹤0.01% | 2464 |
|
|
2018
Q2 | $1.33M | Buy |
+18,571
| New | +$887K | ﹤0.01% | 2971 |
|
Other funds holding RGNX
RG
Dimensional Fund Advisors's RGNX Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Regenxbio (RGNX) stake by 28% in Q2 2026, selling an estimated $2.31M and leaving 731,586 shares worth $8.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2363.
Dimensional Fund Advisors first reported a position in RGNX in Q2 2018 and has held it in 32 quarters since. The position peaked at $37M in Q2 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Dimensional Fund Advisors held 731,586 shares of Regenxbio worth $8.76M as of Q2 2026.
- Dimensional Fund Advisors sold 278,795 Regenxbio shares in Q2 2026, an estimated $2.31M.
- Regenxbio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2363 holding.
- Dimensional Fund Advisors first reported a position in Regenxbio in Q2 2018 and has held it in 32 quarters since.
- Dimensional Fund Advisors's Regenxbio position peaked at $37M in Q2 2021.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.